(1-(tert-Butoxycarbonyl)-1H-indazol-5-yl)boronic acid

Catalog No. :
ACNGSX864
CAS No. :
1167418-12-3
Molecular Formula :
C12H15BN2O4
Molecular Weight :
262.07

IUPAC Name:(1-(tert-butoxycarbonyl)-1H-indazol-5-yl)boronic acid

(1-(tert-Butoxycarbonyl)-1H-indazol-5-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$51.00Login to see priceIn stockInquiry
1g95%$128.00Login to see priceIn stockInquiry
5g95%$348.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-(tert-Butoxycarbonyl)-1H-indazol-5-yl)boronic acid
IUPAC Name(1-(tert-butoxycarbonyl)-1H-indazol-5-yl)boronic acid
MDL No.MFCD18837754
Molecular FormulaC12H15BN2O4
Molecular Weight262.07
SMILESOB(C1=CC2=C(N(C(OC(C)(C)C)=O)N=C2)C=C1)O
InChI KeyUPCYSNYVECFOJZ-UHFFFAOYSA-N
Synonym1-BOC-INDAZOLE-5-BORONIC ACID;1-Boc-1H-indalzole-5-boronic acid;(1-(tert-Butoxycarbonyl)-1H-indazol-5-yl)boronic acid;1H-Indazole-1-carboxylic acid, 5-borono-, 1-(1,1-dimethylethyl) ester;(1-(tert-Butoxycarbonyl)-1H-indazol-5-yl)boronic acid - [B88400]
CAS No.1167418-12-3
PubChem CID67425052

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNGSX864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLQSC935 route compound structure diagram
    ACLQSC935864771-44-8 In Stock
  2. Then
  3. ACNGSX864 route product structure diagram
    ACNGSX8641167418-12-3 In Stock
Inquiry

2. ACNGSX864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDRHB843 route compound structure diagram
    ACDRHB843338454-14-1 In Stock
  4. Then
  5. ACNGSX864 route product structure diagram
    ACNGSX8641167418-12-3 In Stock
Inquiry

Comments (0)